missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18148586

STAT1 Antibody (OTI4H9), FITC, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-74375F

Product Code. 18148586

  • € 807.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

STAT1 Monoclonal specifically detects STAT1 in Human, Mouse, Rat, Canine, Monkey, Primate samples. It is validated for Immunohistochemistry, Immunocytochemistry/Immunofluorescence.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

STAT1
Monoclonal
FITC
PBS with 0.05% Sodium Azide
STAT1
Full length recombinant protein of human STAT1 (NP_009330) produced in HEK293T cells.
0.1 mL
Primary
Human, Mouse, Rat, Canine, Monkey, Primate
IgG1
Immunohistochemistry, Immunocytochemistry, Immunofluorescence
OTI4H9
Immunohistochemistry, Immunocytochemistry/Immunofluorescence
DKFZp686B04100, ISGF-3,91kD, signal transducer and activator of transcription 1, 91kDa, signal transducer and activator of transcription-1
Mouse
Affinity Purified
Apoptosis, Breast Cancer, Cancer, Myeloid derived Suppressor Cell, Phospho Specific, Signal Transduction, Transcription Factors and Regulators
6772.0
Store at 4°C in the dark.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.